In Vivo Liver-targeted Transfection Reagent
Research tool for delivery to liver and tumor tissues
Key Facts
About Altogen Biosystems
Altogen Biosystems leverages its expertise in polymer-stabilized liposomes, nanoparticles, and polymer chemistry to create optimized transfection solutions for delivering biomolecules like plasmid DNA, siRNA, mRNA, and proteins. Its technology has been cited in high-impact journals including Nature, Nature Medicine, and Nature Biotechnology, validating its research applications. The company operates a dual business model, selling proprietary transfection reagents while also offering comprehensive CRO services through Altogen Labs to support drug discovery and IND-enabling studies. Its strategic focus is on enabling gene function studies and therapeutic delivery across oncology, cardiovascular, metabolic, and infectious diseases.
View full company profile